OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Heart and Lung Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	535
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	256
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	159
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	115
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	105
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	101
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	97
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	84
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	84
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	77
Early Onset Malignancy in the First-Year After Heart Transplantation	71
Older Donor Hearts for Heart Transplantation	67
WITHDRAWN	66
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	63
Comparative Analysis of Fontan Transplant Outcomes	63
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	62
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	59
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	58
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	58
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	57
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	54
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	53
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	52
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	52
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	51

Utility of Breath Volatomic Analysis in Lung Transplant Recipients	49
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	48
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	48
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	47
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	47
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	45
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	43
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	43
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	43
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	42
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	41
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	40
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	39
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	38
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	38
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	38
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	37
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	36
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	36
A signal that hypothermia reduces inflammation during donor heart preservation, and a reminder that large animal models remain vital to the development of iterative improvements in myocardial preserva	35
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	35
Why LVAD use is stagnant: A failure of diffusion and a path forward	35
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	35
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	34
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	33
First North American Experience with The Berlin Heart Active Driver	32
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	32
Extending the bridge, bridging the gap	32
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	31
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	31
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	30
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	30
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	29
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	29
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	29
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	29
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	28
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	28
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	28
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	28
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	27
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	27
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	27
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	27
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	26
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	26
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	26
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	26
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	26
Use of Heart in Donor Death Caused by Lightning	26

A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	26
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	26
Information for Readers	25
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	25
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	25
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	25
Information for Readers	24
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	24
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	24
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	24
Table of Contents	24
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	24
(911) Older Donors in Lung Transplantation: The Portuguese Experience	24
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	24
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	23
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	23
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	23
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	23
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	23
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	22
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	22
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	22
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	22
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	22
ISHLT 2023 Author Index	22
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	22
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	22
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	22
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	22
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	22
Ex-vivo lung perfusion: National trends and post-transplant outcomes	21
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	21
Defining Patient-Specific Baseline Donor-Derived Cell-Free DNA in Lung Transplantation	21
Dynamic dd-cfDNA Levels and Risk of Cardiac Allograft Dysfunction: A Time-Varying Cox Analysis	21
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	21
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	21
A Novel Risk Score for 1-Year Mortality Following Donation After Circulatory Death Heart Transplantation	21
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	21
Investigating Vectorcardiography as a Marker of Myocardial Remodeling in Patients Supported by Left Ventricular Assist Devices	21
Right Ventricular Failure in a Patient with LVAD Confounded by CardioMEMS Readings: A Case Report	21
Renal Outcomes in Cardiogenic Shock Managed with Impella 5.5 as a Bridge to Orthotopic Heart Transplant	20
Only Time Will Tell: Early versus Delayed Tacrolimus Initiation in Heart Transplant Recipients without Induction	20
A Comparison of Postoperative Hemodynamic Trajectories in Donation After Brain Death versus Circulatory Death Heart Transplantation	20
Donor Derived cfDNA% Kinetic Patterns are Associated with Longitudinal Spirometry Trajectory After Lung Transplantation	19
Recipient Risk Stratification Using Index for Mortality Prediction After Cardiac Transplantation (IMPACT) Score in DCD Cohort	19
Viscoelastic Tests Did Not Reduce Transfusion During Lung Transplantation	19
Machine Learning Leads To Earlier, Real-time Predictions Of Lung Transplant Acceptance During rc-EVLP	19
Donor Coronary Artery Disease Does Not Adversely Affect 1-Year Survival After DCD Heart Transplant: A UNOS Database Analysis	19
Diagnostic Performance of Donor-Derived Cell-Free DNA After Conversion to Sirolimus in Heart Transplant Recipients	19
Achieving Safe and Equitable Access to Heart Transplantation in Recipients with HIV: A Contemporary National Study	19
Using CMR to Diagnose Acute Graft Rejection Post Heart Transplant: Case Report	19
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	19
Quadruple Immunosuppression in a Patient with Persistent Donor Specific Antibodies: When is It Time to Consider Other Therapies?	19
Improvement in 2 Year Outcomes with the SherpaPak Cardiac Transport System: A Large, Single-Center Experience	19
Use of Controlled Hypothermic Lung Preservation to Optimize Outcomes in Older Recipients	19
A Cellular Single-Nucleus RNA Atlas of the Chronic Lung Allograft Dysfunction Spectrum from Small Airway Disease to Parenchymal Fibrosis	19
Quality of Life and Decision Regret After Left Ventricular Assist Device Implantation: Insights from the Distressed Community Index	19
Bletilla Striata Polysaccharide Attenuates Ischemia-Reperfusion Injury After Lung Transplantation in Rats by Inhibiting NLRP3-Mediated Pyroptosis	18
Multilayer Networks Reveal Centrality Rewiring in Heart Transplant Rejection and Infection	18
Optical-Flow Analysis Demonstrates Preserved Contractility and In-Vivo Function After 24-Hour of Hypothermic Oxygenated Perfusion in Porcine Hearts	18
Urinary Cell Cycle Arrest Biomarkers for the Early Prediction of Acute Kidney Injury After Lung Transplantation	18
Effect of GLP1-Receptor Agonist Therapies for Patients with a LVAD and Obesity: A Case Series	18
Personalized Platelet Inhibition on Paracorporeal Ventricular Assist Device Support: Single-Center Experience with Pediatric Pharmacogenomic Testing	18
Heart Failure Phenotypes and Outcomes After TAVR vs SAVR: A Trinetx Database Analysis	18
Isolated Plasma Rich Liver Rejection in Combined Heart-Liver Transplant	18
Impact of Low Donor/Recipient Predicted Heart Mass Ratio on PGD and Survival: A Report from the Organ Heart Perfusion Registry	18
Hospital Length of Stay After Heart Transplantation with Durable or Temporary Mechanical Circulatory Support	18
The Impact of Intraoperative Hypothermia on Surgical Site Infections in Pediatric Heart Transplant	18
Efficacy and Safety of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy After Heart Transplant (ACAV Trial, NCT04193306)	18
Ischemia-Reperfusion Injury (IRI) Drives Epithelial and Endothelial Cell-Surface GRP78 (csGRP78) Expression and Anti-GRP78 Humoral Autoimmunity in a Mouse Lung Transplant (LTx) Model of Chronic Lung A	18
10°C Storage Preserves Metabolic Reserve and Reduces Oxygen Debt in Heart Transplantation	18
Towards a Paradigm Shift in Cystic Fibrosis Lung Transplantation: Re-Transplantation Era	18
How to Stratify Cardiovascular (CV) Prognosis in Heart Transplanted (HT) Patients: Do Tools of the General Population Work?	18
Transcriptomic Profiling of Donor-Heart Tissue Across Organ Procurement Modalities	17
Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death	17
Tick Tock Goes the Clock: Normothermic Machine Perfusion versus Static Cold Storage at 10°C for Extended Preservation of Cardiac Allografts	17
Single-Nuclei Transcriptomic Atlas of Chronic Lung Allograft Dysfunction Reveals Distinct Molecular and Cellular Signatures in BOS and RAS	17
A Novel Risk Score for Right Heart Failure Following Contemporary LVAD Implants	17
Use of a Novel Risk Score (MARKER-HF) to Predict Outcomes After Heart Transplant	17
Establishing Australia’s First Paediatric DCD Heart Transplant Program	17

Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	16
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	16
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	16
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	16
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	16
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	16
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	16
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	16
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	16
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	16
Optimizing the handling of missing data in the UNOS database	16
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	16
Impact of Logistic Challenges on Cardiac Transplantation	16
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	16
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	16
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	15
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	15
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	15
Impact of coronary hypoperfusion during agonal phase on outcomes following donation after circulatory death heart transplantation	15
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	15
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	15
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	15
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	15
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	15
Letter to the Editor: Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1	15
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	15
Metabolic vulnerability and opportunity in donation after circulatory death heart transplantation: Oxygen extraction ratio as a physiologic bridge between donor injury and recipient outcomes	15
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	15
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	15
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	15
Extra-cardiac management of cardiogenic shock in the intensive care unit	15
Re-evaluating ischemic tolerance and prognostic accuracy in DCD cardiac transplantation: A critical appraisal of taNRP outcomes	14
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	14
Information for Readers	14
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	14
Shock Teams Grow Volume and Improve Outcomes in Cardiogenic Shock	14
Does Donor-Recipient Age Mismatch Affect Long-Term Immunological Outcomes? A 10-Year Single Center Study	14
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	14
Metabolomic signature of right ventricular–pulmonary arterial coupling differentiates hemodynamic response to imatinib therapy in pulmonary arterial hypertension	14
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	14
Towards a nuanced understanding of donor risk	14
WITHDRAWN	14
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	14
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	14
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	14
Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study	14
Table of Contents	14
Current Global Trends and Challenges Utilizing Pediatric Ventricular Assist Devices: An Action Collaborative Survey	14
Long-Term Outcomes of Ventricular Assist Devices in Obese Pediatric Patients: An ACTION Registry Study	13
Initial Analysis of Immune Phenotypes in Heart Transplant Recipients of the ALL IN HEART (Tocilizumab) Trial	13
Combination Approach of Perioperative Plasmapheresis and Eculizumab for Highly Sensitized Lung Transplant Patients	13
Improving Efficiency in Pharmacist Led Thoracic Transplant Patient Medication Education	13
Left Ventricular Stenting - A Novel Technique for LVAD Implantation in Patients with Restrictive Cardiomyopathy	13
Application of Optical Mapping for Assessing Ischemic Regions in Donor Hearts: A Novel Approach to Monitoring Action Potential Hysteresis and Triangulation	13
Gut Reaction: Gastroesophageal Reflux Fuels De Novo DSA Development After Lung Transplant	13
Early Rejection and Graft Vasculopathy in DCD Hearts: A Comparison of Recovery Methods	13
Microcirculation as a Predictor of Clinical Outcomes in Left Ventricular Assist Device Therapy	13
Reversion of Val(ganciclovir)-Resistance Associated Mutation in Two SOT Patients with Mismatch Serostatus for CMV (D+/R-)	13
Differences in Prevention, Diagnosis, Surveillance and Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results of an International Survey	13
Porcine Mitochondria Transplantation in Human iPS-Cardiomyocytes and Intact Hearts	13
A Rare Case of HeartMate 3 Pump Stoppage	13
Tuberculosis Post Lung Transplantation - An Indian Experience	13
Evaluating Postoperative Outcomes of Heart Transplant Recipients from Active COVID19 Positive and Negative Donors Using Induction Therapy	13
Durable Ventricular Assist Device Support with Systemic Right Ventricle Cannulation	13
Kratom Toxicity: A Mimicker of Fulminant Myocarditis	13
MHC Class II Matching Does Not Predict Survival in Organ and Bone Marrow Transplantation in Non-Human Primates	13
Plasmablastic Lymphoma in a Lung Transplant Recipient	13
Impact of Preoperative Opioid Use in Lung Transplant Recipients	13
Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry	12
Esophagogastric Junction (EGJ) Outflow Obstruction is Associated with Chronic Lung Allograft Dysfunction (CLAD)	12
Largest Real-World Multi-Center Study Outcomes Reported with Controlled Hypothermic Preservation of Donor Lungs	12
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	12
Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported with CF-LVADs?	12
Patients with Acute Lung Rejection Have a Worse Outcome After Combined Heart-Lung Transplantation	12
Use and Outcomes of Ex-Vivo Machine Perfusion (EVMP) in Donation After Brain Death (DBD) Heart Transplantation (HT)	12
Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantation	12
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	12
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	12
Hemodynamics at Submaximal Exercise Independently Predict Outcomes in Severe Heart Failure	12
First Sub-Zero Cardiac Allograft Preservation and Reanimation Following 24-Hours of Isochoric Supercooled Preservation	12
ADAM10-Mediated VE-Cadherin Shedding May Increase the Risk of Sepsis for Heart Failure Patients Supported by Continuous-Flow Left Ventricular Assist Devices	12
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients	12
Non-Ischemic Preservation of the Donor Heart in Heart Transplantation - A Randomized, Controlled, Multicenter Trial Using The Xvivo Heart Assist Preservation System for Hypothermic Oxygenated Perfusio	12
The Impact of Functional Warm Ischemia Time on Procurement and Preservation Technique in DCD Heart Transplantation	12
Use of Newer Intravascular Microaxial Ambulatory Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock in Adult Congenital Heart Disease Patients	12
Unlocking the black box of heart preservation	11
Identification and Clinical Course of Novel Pathogenic Variant of Transthyretin Amyloid Cardiomyopathy: P.arg54lys	11
Incorporating Donor Variables Improves Accuracy of One-Year Post-Transplant Survival Prediction for Adult Heart Transplant Recipients	11
Digoxin Reverses Angiogenic Dysregulation During HeartMate 3 Support by Inhibiting the HIF1-a Signaling Cascade and is Associated with Decreased Risk for Gastrointestinal Bleeding	11
Axillary Temporary Mechanical Circulatory Support to Bridge Cardiogenic Shock Patients to Heart Transplantation	11
Impact of Innate Rejection on Graft Survival in Heart Transplantation: Preliminary Findings on Missing-Self Induced Microvascular Rejection	11
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis	11
SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	11
Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients	11
Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation	11